Pharmaceutical biotechnology is the use of biotechnological methods to obtain products from animal, plant and microbial organisms or their parts. In pharmaceutical studies, "biological products" usually refer to blood-derived medicinal products, vaccines, toxins and allergen products, while "Biotechnological products" have a much broader and deep-rooted meaning. Basically it refers to the use of biological systems (eg cells or tissues) or biological molecules (eg enzymes or antibodies) in them for the production of commercial products. While biopharmaceuticals or biotechnological products are considered to be proteins produced through genetic engineering that are approved or under development, these terms also include nucleic acid-based products, i.e. deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) based products and whole cell-based products in recent years.
Designing new therapeutic drugs, developing diagnostic agents for medical tests, gene therapy, recombinant DNA technology, production and formulation of peptides and proteins, DNA vaccines, monoclonal antibodies and their carrier systems are the main areas of study of Pharmaceutical Biotechnology.
The courses currently offered by the Pharmaceutical Biotechnology Department are;
- Pharmaceutical Biotechnology,
- Recombinant DNA Techniques,
- Herbal Biotechnology